Comparison of drug survival rates for tumor necrosis factor antagonists in rheumatoid arthritis

Overview of attention for article published in Patient preference and adherence, July 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 49 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

Association of first, second, and third-line bDMARDs and tsDMARD with drug survival among seropositive rheumatoid arthritis patients: Cohort study in A real world setting

Article in Seminars in Arthritis and Rheumatism (June 2021)

Factors affecting persistence with biologic treatments in patients with rheumatoid arthritis: a systematic literature review

Article in Expert Opinion on Drug Safety (May 2021)

GO-BEYOND: a real-world study of persistence of golimumab in patients with axial spondyloarthritis and rheumatoid arthritis in Turkey

Article in Immunotherapy (May 2021)